DE60226151D1 - Verbessertes verfahren zur membranpotentialmessung - Google Patents

Verbessertes verfahren zur membranpotentialmessung

Info

Publication number
DE60226151D1
DE60226151D1 DE60226151T DE60226151T DE60226151D1 DE 60226151 D1 DE60226151 D1 DE 60226151D1 DE 60226151 T DE60226151 T DE 60226151T DE 60226151 T DE60226151 T DE 60226151T DE 60226151 D1 DE60226151 D1 DE 60226151D1
Authority
DE
Germany
Prior art keywords
probes
membrane potential
measurement method
potential measurement
improved membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60226151T
Other languages
English (en)
Other versions
DE60226151T2 (de
Inventor
Dieter Klaubert
Zhenjun Diwu
Guoliang Yi
Martin Kirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Devices LLC
Original Assignee
MDS Analytical Technologies US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MDS Analytical Technologies US Inc filed Critical MDS Analytical Technologies US Inc
Publication of DE60226151D1 publication Critical patent/DE60226151D1/de
Application granted granted Critical
Publication of DE60226151T2 publication Critical patent/DE60226151T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Fuel Cell (AREA)
DE60226151T 2001-08-08 2002-08-07 Verbessertes verfahren zur membranpotentialmessung Expired - Lifetime DE60226151T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US924797 2001-08-08
US09/924,797 US6852504B2 (en) 2001-08-08 2001-08-08 Method for measuring cellular transmembrane potential changes
PCT/US2002/025046 WO2003014701A2 (en) 2001-08-08 2002-08-07 Potentiometric probe compounds

Publications (2)

Publication Number Publication Date
DE60226151D1 true DE60226151D1 (de) 2008-05-29
DE60226151T2 DE60226151T2 (de) 2009-05-28

Family

ID=25450742

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60226151T Expired - Lifetime DE60226151T2 (de) 2001-08-08 2002-08-07 Verbessertes verfahren zur membranpotentialmessung

Country Status (6)

Country Link
US (2) US6852504B2 (de)
EP (1) EP1421206B1 (de)
AT (1) ATE392484T1 (de)
CA (1) CA2456115C (de)
DE (1) DE60226151T2 (de)
WO (1) WO2003014701A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852504B2 (en) * 2001-08-08 2005-02-08 Molecular Devices Corporation Method for measuring cellular transmembrane potential changes
US8329390B2 (en) * 2004-10-21 2012-12-11 Anaspec Incorporated Detection of transmembrane potentials using N,N,N′-trialkyl thiobarbituric acid-derived polymethine oxonols
DE102007012029A1 (de) * 2007-03-13 2008-09-18 Grünenthal GmbH Verfahren zur Identifizierung der agonistischen Aktivität einer Zielverbindung auf einen Kaliumkanal
KR20100016073A (ko) * 2007-04-02 2010-02-12 인스티튜트 포 원월드 헬스 Cftr 억제제 화합물 및 이의 용도
US20090263853A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health High-Throughput Cell-Based CFTR Assay
WO2009131957A2 (en) 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
WO2009131951A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
JP2012503005A (ja) * 2008-09-19 2012-02-02 インスティテュート フォア ワンワールド ヘルス イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。
US8511216B2 (en) * 2009-03-30 2013-08-20 Kanzaki Kokyukoki Mfg. Co., Ltd. Hydraulic actuator unit
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
CN112945924A (zh) * 2021-02-03 2021-06-11 南通大学 一种高通量筛选KSper缺陷不育人精子样本的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1597482B2 (de) * 1967-09-22 1977-03-24 Agfa-Gevaert Ag, 5090 Leverkusen Lichtempfindliches photographisches aufzeichnungsmaterial mit lichthofschutz- oder filterfarbstoffen
US4370401A (en) * 1979-12-07 1983-01-25 Minnesota Mining And Manufacturing Company Light sensitive, thermally developable imaging system
GB2136590B (en) * 1983-03-15 1986-01-02 Minnesota Mining & Mfg Dye-bleach materials and process
US6342379B1 (en) * 1995-06-07 2002-01-29 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
US6596522B2 (en) * 1997-05-08 2003-07-22 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
US6143516A (en) * 1998-09-25 2000-11-07 Xoma Technology Ltd. Identification of novel antimicrobial agents using membrane potential indicator dyes
US6537771B1 (en) * 1999-10-08 2003-03-25 Caliper Technologies Corp. Use of nernstein voltage sensitive dyes in measuring transmembrane voltage
US6287758B1 (en) * 2000-03-23 2001-09-11 Axiom Biotechnologies, Inc. Methods of registering trans-membrane electric potentials
US6852504B2 (en) 2001-08-08 2005-02-08 Molecular Devices Corporation Method for measuring cellular transmembrane potential changes

Also Published As

Publication number Publication date
CA2456115A1 (en) 2003-02-20
ATE392484T1 (de) 2008-05-15
CA2456115C (en) 2011-07-19
EP1421206B1 (de) 2008-04-16
WO2003014701A2 (en) 2003-02-20
DE60226151T2 (de) 2009-05-28
US6852504B2 (en) 2005-02-08
US20050153275A1 (en) 2005-07-14
WO2003014701A3 (en) 2003-11-13
US7358064B2 (en) 2008-04-15
EP1421206A2 (de) 2004-05-26
EP1421206A4 (de) 2006-02-15
US20030087332A1 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
ATE392484T1 (de) Verbessertes verfahren zur membranpotentialmessung
ATE304706T1 (de) System zur messung des elektrischen potentials durch eine membrane
DE60239552D1 (de) Messung der protein-syntheseraten bei menschen und in experimentellen systemen durch verwendung von isotopisch markiertem wasser
DE60030948D1 (de) Transmissionsmessgerät, Verfahren zur Transmissionsmessung und Desinfektionsvorrichtung
ATE458987T1 (de) Intelligentes system zur optischen messung von proben
ATE525656T1 (de) Proteinmessverfahren
ATE123572T1 (de) Indikatorsubstanz einer fluoreszenzoptischen messanordnung zur messung des ph-wertes einer probe sowie optischer sensor mit einer derartigen indikatorsubstanz.
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
FI20031357A0 (fi) Monikäyttöinen laitteisto näytteiden optiseen mittaukseen
DK0670493T3 (da) Analyse til bestemmelse af protein i en biologisk prøve
DE69105978T2 (de) Verfahren zur verminderung von störungen in einer fluoreszenzbestimmung.
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE195977T1 (de) Verfahren zur quantitativen bestimmung einer nukleinsäure in einer lösung durch messung der elektrischen leitfähigkeit und vorrichtung dafür
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602004003798D1 (de) Standard für immunhistochemie, immunzytologie und molekulare zytogenetika
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
Willan et al. Comparison of the dimensions of the combining sites of the dinitrophenyl-binding immunoglobulin A myeloma proteins MOPC 315, MOPC 460 and XRPC 25 by spin-label mapping
DE60220288D1 (de) Bestimmung der Genauigkeit eines Probevolumens in Biosensoren
Smith The development of a rapid test for determining the transport properties of concrete
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
Du et al. Preparation and properties of polyether scale inhibitor containing fluorescent groups
DE69414405T2 (de) Verfahren zur messung metaplastischer veränderungen von schleimabsondernden epithelzellen
WILLAN et al. and XRPC 25 by Spin-Label Mapping
SU1257519A1 (ru) Способ определени гликозаминогликанов в жидких средах
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome

Legal Events

Date Code Title Description
8364 No opposition during term of opposition